Clinical trial
Cellular Aging and Neurobiology of Depression Study
NCT00285935 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00285935 |
|---|---|
| Title | Cellular Aging and Neurobiology of Depression Study |
| Official title | Neurosteroid Metabolism and the Antidepressant Effects of Serotonin Specific Reuptake Inhibitors (SSRI's) |
| Acronym | CAN-D |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | National Institutes of Health (NIH) NIH National Institute of Mental Health (NIMH) |
| Status | Completed |
| Study type | Interventional |
| Conditions | Major Depressive Disorder |
| Intervention type | Other |
| Interventions | Standard Clinical Care with an SSRI |
| Enrollment | 228 |
| Start date | Dec 16, 2010 |
| Primary completion | Aug 20, 2025 |
| Completion | Aug 22, 2025 |
| First posted | Feb 2, 2006 |
| Last update posted | Sep 23, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: